- Trials with a EudraCT protocol (188)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (36)
188 result(s) found for: Tachycardia.
Displaying page 1 of 10.
EudraCT Number: 2015-001129-17 | Sponsor Protocol Number: LDLL300.301 | Start Date*: 2017-06-19 | ||||||||||||||||||||||||||||||||||||
Sponsor Name:AOP Orphan Pharmaceuticals GmbH | ||||||||||||||||||||||||||||||||||||||
Full Title: A multicenter, open-label study to investigate the effectiveness and safety of AOP Landiolol in controlling supraventricular tachycardia in pediatric patients (LANDI-PED). | ||||||||||||||||||||||||||||||||||||||
Medical condition: Supraventricular tachycardia in pediatric patients. | ||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||
Population Age: Newborns, Infants and toddlers, Children, Adolescents, Under 18 | Gender: Male, Female | |||||||||||||||||||||||||||||||||||||
Trial protocol: AT (Completed) DE (Ongoing) LT (Completed) HU (Completed) | ||||||||||||||||||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2020-003005-61 | Sponsor Protocol Number: BGP-15-CLIN-06 | Start Date*: 2020-09-30 | |||||||||||
Sponsor Name:Sinusventure LLC. | |||||||||||||
Full Title: A phase 2 study on the clinical efficacy of adjuvant BGP-15 treatment additional to beta-blocker bisoprolol in patients with inappropriate sinus tachycardia | |||||||||||||
Medical condition: Inappropriate sinus tachycardia | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: HU (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2010-023311-34 | Sponsor Protocol Number: CPA 368-10 | Start Date*: 2011-02-04 | |||||||||||
Sponsor Name:AOP Orphan Pharmaceuticals AG | |||||||||||||
Full Title: A prospective, randomized, double blinded, crossover, two-treatment, two-sequence, short term pharmacokinetic, pharmacodynamic and tolerability, single centre study to compare AOP200704 vs. Esmolol... | |||||||||||||
Medical condition: healthy male and female volunteers, intended for the treatment of dobutamine-induced tachycardia | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: CZ (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2009-011560-11 | Sponsor Protocol Number: CL2-44121-005 | Start Date*: 2010-01-22 | |||||||||||
Sponsor Name:Institut de Recherches Internationales Servier | |||||||||||||
Full Title: Effects of three oral dosages of S 44121 on cardiac arrhythmia during exercise testing in patients with catecholaminergic polymorphic ventricular tachycardia type 1. A 3-day, single-blind, internat... | |||||||||||||
Medical condition: Catecholaminergic polymorphic ventricular tachycardia (CPVT) type 1 | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FI (Completed) FR (Completed) IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2011-001287-22 | Sponsor Protocol Number: FLECAINIDE-1 | Start Date*: 2011-04-18 | |||||||||||
Sponsor Name:FONDAZIONE SALVATORE MAUGERI - CLINICA DEL LAVORO E DELLA RIABILITAZIONE | |||||||||||||
Full Title: A Prospective Randomized Crossover trial of Oral Flecainide for Catecholaminergic Polymorphic Ventricular Tachycardia | |||||||||||||
Medical condition: Patients with CPVT and ICD | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18, Adults | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2011-000579-15 | Sponsor Protocol Number: CL2-44121-008 | Start Date*: 2012-02-01 | |||||||||||
Sponsor Name:Institut de Recherches Internationales Servier | |||||||||||||
Full Title: Effects of acute and chronic oral administration of S 44121 versus placebo on cardiac arrhythmia during exercise testing in patients with catecholaminergic polymorphic ventricular tachycardia type ... | |||||||||||||
Medical condition: Catecholaminergic polymorphic ventricular tachycardia type 1 | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: FI (Prematurely Ended) DE (Prematurely Ended) GB (Prematurely Ended) NL (Prematurely Ended) IT (Prematurely Ended) HU (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2014-001380-13 | Sponsor Protocol Number: PROPADB-01 | Start Date*: 2014-08-08 |
Sponsor Name:Abelardo Garcia De Lorenzo / Teresa Nuñez-Villaveiran | ||
Full Title: Effects of the treatment with propranolol in the burnt adult intubated patient with sinusal tachycardia induced by burns. | ||
Medical condition: BURNT-INDUCED SINUSAL TACHYCARDIA | ||
Disease: | ||
Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | |
Trial protocol: ES (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2010-023495-11 | Sponsor Protocol Number: 2010-023495-11 | Start Date*: 2010-12-17 | |||||||||||
Sponsor Name:AZIENDA UNIVERSITARIA POLICLINICO UMBERTO I DI ROMA | |||||||||||||
Full Title: Esmolol to treat tachicardia in septic shock | |||||||||||||
Medical condition: septic shock | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2018-000308-41 | Sponsor Protocol Number: MSP-2017-1138 | Start Date*: 2020-12-14 | |||||||||||
Sponsor Name:Milestone Pharmaceuticals Inc. | |||||||||||||
Full Title: Multi-Centre, Randomized, Double-Blind, Placebo-Controlled, Efficacy, and Safety Study of Etripamil Nasal Spray for the Termination of Spontaneous Episodes of Paroxysmal Supraventricular Tachycardi... | |||||||||||||
Medical condition: Treatment of Paroxysmal Supraventricular Tachycardia | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Completed) BE (Completed) PL (Completed) FR (Completed) DE (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2007-006334-33 | Sponsor Protocol Number: AJUAR | Start Date*: 2008-03-19 | |||||||||||||||||||||
Sponsor Name:Dr. Josep Brugada Terradellas- Hospital Clínic | |||||||||||||||||||||||
Full Title: Utilidad de la ajmalina intravenosa en el diagnóstico y tratamiento de las arritmias cardíacas | |||||||||||||||||||||||
Medical condition: Fibrilación auricular Taquicardia ventricular monomórfica sostenida Diagnóstico de Síndrome de Brugada | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Children, Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: ES (Completed) | |||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2012-005292-14 | Sponsor Protocol Number: not_applicable | Start Date*: 2013-01-09 | |||||||||||
Sponsor Name:Heikki Swan | |||||||||||||
Full Title: Dantrolene in catecholaminiergic polymorphic ventricular tachycardia | |||||||||||||
Medical condition: Catecholaminergic polymorphic ventricular tachycardia | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FI (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2016-004455-78 | Sponsor Protocol Number: SINUS | Start Date*: 2017-06-09 |
Sponsor Name:Region Östergötland | ||
Full Title: Sedation with propofol and remifentanil during ventricular tachycardia treatment: patient-controlled versus nurse anesthetists controlled - a randomized controlled trial | ||
Medical condition: Percutaneous pericardial access for mapping and ablation of ventricular tachycardia | ||
Disease: | ||
Population Age: Elderly | Gender: Male, Female | |
Trial protocol: SE (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2017-002138-22 | Sponsor Protocol Number: LDLL300.401 | Start Date*: 2017-09-15 | ||||||||||||||||
Sponsor Name:AOP Orphan Pharmaceuticals GmbH | ||||||||||||||||||
Full Title: Phase IV, multicenter, prospective, randomized, open-label, controlled study on Landiolol in patients with septic shock resident in ICUs | ||||||||||||||||||
Medical condition: Adult patients in ICU with septic shock who remain tachycardic (HR ≥95 bpm) and require vasopressor therapy to maintain a Mean arterial pressure (MAP) of ≥65 mmHg after a hemodynamic optimization p... | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: AT (Completed) DE (Completed) CZ (Completed) SI (Completed) HU (Completed) LT (Completed) PL (Completed) EE (Completed) IT (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2017-001785-14 | Sponsor Protocol Number: STRESS-L | Start Date*: 2017-11-09 | ||||||||||||||||
Sponsor Name:University Hospitals Birmingham NHS Foundation Trust | ||||||||||||||||||
Full Title: STRESS-L: STudy into the REversal of Septic Shock with Landiolol (Beta Blockade) | ||||||||||||||||||
Medical condition: Tachycardia in Septic Shock | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2015-005743-14 | Sponsor Protocol Number: 15.0214 | Start Date*: 2016-04-15 |
Sponsor Name:St Georges University Hospital NHS Foundation Trust | ||
Full Title: Fetal Atrial Flutter & Supraventricular Tachycardia (FAST) Therapy Trial | ||
Medical condition: Fetal atrial flutter without hydrops, supraventricular tachycardia without hydrops and supraventricular tachycardia with hydrops | ||
Disease: | ||
Population Age: In utero, Preterm newborn infants, Under 18 | Gender: Male, Female | |
Trial protocol: GB (GB - no longer in EU/EEA) | ||
Trial results: (No results available) |
EudraCT Number: 2019-001857-13 | Sponsor Protocol Number: NODE-303 | Start Date*: 2020-04-09 | |||||||||||
Sponsor Name:Milestone Pharmaceuticals Inc. | |||||||||||||
Full Title: Multi-Centre, Multi-National, Open Label, Safety Study of Etripamil Nasal Spray for Patients with Paroxysmal Supraventricular Tachycardia | |||||||||||||
Medical condition: Treatment of Paroxysmal Supraventricular Tachycardia | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Completed) BE (Completed) NL (Completed) DE (Completed) HU (Completed) DK (Completed) CZ (Completed) SK (Completed) GB (GB - no longer in EU/EEA) ES (Prematurely Ended) PL (Completed) IT (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2008-001201-42 | Sponsor Protocol Number: 4-001-LVS | Start Date*: 2008-06-01 | |||||||||||
Sponsor Name:POLICLINICO SAN DONATO IRCSS | |||||||||||||
Full Title: Clinical trial on the use of ivabradine in patients with inappropriate sinus tachycardia | |||||||||||||
Medical condition: Inappropriate sinus tachycardia | |||||||||||||
|
|||||||||||||
Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2004-004864-54 | Sponsor Protocol Number: BCBe/04/Neb-Car/082 | Start Date*: 2005-09-12 |
Sponsor Name:Berlin-Chemie Menarini | ||
Full Title: COMPARISON OF THE EFFECTS OF COMBINED RATE- AND RHYTHM-CONTROL TREATMENT WITH NEBIVOLOL AND ELECTRIC CARDIOVERSION TO RATE-CONTROL TREATMENT WITH NEBIVOLOL ALONE ON CLINICAL AND ECHOCARDIOGRAPHIC P... | ||
Medical condition: PATIENTS WITH HYPERTENSION AND LEFT-VENTRICULAR DYSFUNCTION INDUCED BY TACHYCARDIA | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Completed) | ||
Trial results: View results |
EudraCT Number: 2005-000671-17 | Sponsor Protocol Number: 3163 K1-200-WW | Start Date*: 2005-10-05 |
Sponsor Name:Wyeth Research Division of Wyeth Pharmaceuticals Inc., Clinical Research and Development | ||
Full Title: A Safety and Efficacy Dose-Ranging Study of GAP-486 in Subjects With Nonsustained Ventricular Tachycardia and Acute Ischemia | ||
Medical condition: Subjects with coronary artery disease or left ventricular dysfunction experiencing an acute coronary syndrome with non-life-threatening ventricular arrhythmias. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: HU (Prematurely Ended) GB (Prematurely Ended) SE (Prematurely Ended) DK (Completed) IT (Completed) | ||
Trial results: View results |
EudraCT Number: 2011-004903-20 | Sponsor Protocol Number: ABR-38376 | Start Date*: 2012-05-09 |
Sponsor Name: | ||
Full Title: Hydroxychloroquine as an anti-autophagy and chromatin modulating drug in combination with erlotinib in non-small cell lung cancer (NSCLC) patients: a single-center single arm open-label phase II trial | ||
Medical condition: Patients with histologically confirmed stage IV non-squamous non-small-cell lung cancer (NSCLC) • with an activating EGFR mutation who progressed on erlotinib or gefitinib monotherapy. OR • who... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.